April 14, 2023
Life Sciences | Tea Leaves
  • Pharmacy benefit management giant Express Scripts is rolling out multiple new programs in a bid to evolve its model to be more transparent and predictable for patients and plan sponsors. The company, a subsidiary of Cigna’s Evernorth,unveiled¬†two new programs Thursday morning that serve as the cornerstone of the refresh. The first, called Copay Assurance, caps the costs of generic drugs and preferred branded or specialty drugs for members enrolled in the program. The initiative builds on the PBM’s Patient Assurance program, which was launched several years ago to cap the cost of insulin and other diabetes treatments at $25 for a 30-day supply. Under Copay Assurance, generic drugs are capped at $5 for a 30-day supply, preferred brand-name drugs are capped at $25, and preferred specialty brand drugs are capped at $45. (Articles here and here)